Compound Summary
ribavirin
Compound Information
ribavirin
Compound Name: | ribavirin |
Compound CID: | 37542 |
Synonyms: | ribavirin 36791-04-5 Tribavirin Rebetol Virazole More... |
Iupac Name: | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide |
InChI: | InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1 |
InChIKey: | IWUCXVSUMQZMFG-AFCXAGJDSA-N |
Canonical Smiles: | C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N |
Isomeric Smiles: | C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N |
Molecular Weight: | 244.2 |
Molecular Formula: | C8H12N4O5 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
ribavirin
Molecular Weight: | 244.2 |
Molecular Formula: | C8H12N4O5 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 17 |
Complexity: | 304 |
Synonyms
ribavirin
| ribavirin | ribavirin |
|---|---|
ribavirin |
36791-04-5 |
Tribavirin |
Rebetol |
Virazole |
Copegus |
Vilona |
Ribavirine |
Viramid |
RTCA |
Ribamide |
Ribamidil |
Ribasphere |
Ribavirina |
Ribavirinum |
Ribavirine INN-French |
Ribavirinum INN-Latin |
ICN-1229 |
Ribavirina INN-Spanish |
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide |
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide |
RBV |
SCH 18908 |
UNII-49717AWG6K |
Ribamidyl |
Ribavirin (Copegus) |
1-(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1,2,4-triazole-3-carboxamide |
1-(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-1H-1,2,4-triazole-3-carboxamide |
1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide |
MFCD00058564 |
Rebetron |
Varazid |
Ribavirin Capsules |
1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl- |
CHEBI:63580 |
49717AWG6K |
NSC-163039 |
1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide |
Rebretron |
Virazid |
Virazide |
Ribav |
DSSTox_CID_3557 |
DSSTox_RID_77081 |
DSSTox_GSID_23557 |
RTC |
1-(beta-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide |
Cotronak |
Ravanex |
Ribacine |
C-Virin |
DRG-0028 |
Ribasphere (TN) |
Virazole (TN) |
SMR000058315 |
Copegus (TN) |
Rebetol (TN) |
HSDB 6513 |
SR-01000076112 |
BRN 0892462 |
Ribavirine; |
NSC163039 |
Ribavirin USAN:USP:INN:BAN |
Ribavirin,(S) |
NCGC00015904-02 |
Ribavirin, antiviral |
CAS-36791-04-5 |
RG-964 |
Ro-20-9963 |
Spectrum_001826 |
4pb1 |
ribofluranosyl carboxamide |
Prestwick3_000993 |
Spectrum3_001876 |
Spectrum4_001252 |
Spectrum5_002075 |
R-964 |
R 9644 |
SCHEMBL3727 |
CHEMBL1643 |
Lopac0_001063 |
BSPBio_001085 |
BSPBio_003352 |
KBioGR_001804 |
KBioSS_002331 |
cid_37542 |
MLS000028486 |
MLS002222317 |
DivK1c_000782 |
SPECTRUM1503938 |
Ribavirin (JP17/USP/INN) |
BPBio1_001195 |
GTPL6842 |
1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl- |
1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide |
DTXSID8023557 |
HMS502H04 |
KBio1_000782 |
KBio2_002328 |
KBio2_004896 |
KBio2_007464 |
KBio3_002854 |
NINDS_000782 |
HMS2090L15 |
HMS2094O09 |
HMS2098G07 |
HMS2232P07 |
HMS3263E08 |
HMS3715G07 |
Pharmakon1600-01503938 |
HY-B0434 |
ZINC1035331 |
Tox21_110259 |
Tox21_200967 |
Tox21_501063 |
BDBM50154375 |
CCG-38985 |
NSC758650 |
s2504 |
SCH-18908 |
AKOS001715163 |
Tox21_110259_1 |
DB00811 |
GS-3572 |
LP01063 |
MCULE-9495128592 |
NSC-758650 |
SDCCGSBI-0051033.P004 |
IDI1_000782 |
SMP1_000261 |
NCGC00090726-01 |
NCGC00090726-03 |
NCGC00090726-04 |
NCGC00090726-05 |
NCGC00090726-06 |
NCGC00090726-07 |
NCGC00090726-08 |
NCGC00090726-09 |
NCGC00090726-12 |
NCGC00090726-25 |
NCGC00090726-30 |
NCGC00258520-01 |
NCGC00261748-01 |
252269-50-4 |
AS-34178 |
BCP0726000138 |
SBI-0051033.P003 |
AB0068936 |
AB00430481 |
EU-0101063 |
R0077 |
EN300-59237 |
D00423 |
J10190 |
AB00430481-15 |
AB00430481-16 |
AB00430481_17 |
AB00430481_18 |
1-beta-Ribofuranosyl-1,2,4-triazole-3-carboamide |
791R045 |
A823370 |
Q421862 |
Ribavirin 100 microg/mL in Acetonitrile:Methanol |
SR-01000721904 |
SR-01000076112-2 |
SR-01000076112-3 |
SR-01000076112-4 |
SR-01000721904-2 |
1-??-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide |
BRD-K60369935-001-02-7 |
BRD-K60369935-001-18-3 |
SR-01000076112-11 |
1-?-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide |
Ribavirin, British Pharmacopoeia (BP) Reference Standard |
Z1522567185 |
1-(beta -D-ribofuranosyl)-1,2,4-triazole-3-carboxamide |
Ribavirin, European Pharmacopoeia (EP) Reference Standard |
Ribavirin, United States Pharmacopeia (USP) Reference Standard |
Ribavirin, Pharmaceutical Secondary Standard; Certified Reference Material |
1-(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl-1,2,4-triazole-3-carboxamide |
1-(2R,3S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl-1,2,4-triazole-3-carboxamide |
Experimental Data
ribavirin
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | -12.000000000000000 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
ribavirin
Statistics Data
ribavirin
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -12.000000000000000 | 1 | 1 |
Statistics Data Visualization
ribavirin
